Innovating macrophage-targeted therapeutics across multiple therapeutic areas Proprietary functional macrophage fingerprinting technology identifies disease-relevant macrophage subsets Strengthened by the appointments of James Rush as CEO and Jim Van heusden as Chairman Powered by Bioqube Ventures’ venture creation model Spica was founded on groundbreaking research into…

EFI24 January 2025